-
AI
AI in Biopharma: Navigating the “Massive Transition” in Drugmaking Leadership
The artificial intelligence (AI) revolution is causing a fascinating tension in biopharma, as groundbreaking technology clashes with traditional drugmaking methods.…
Read More » -
AI
Pharma’s Struggle to Connect in the Age of Virtual Care
The pharmaceutical industry is struggling to keep pace with rapid changes in healthcare, particularly in how it connects with patients…
Read More » -
Clinical Trials
Pharmaceutical Industry Under Pressure: Where Will Clinical Trial Efficiencies Come From?
The Trump Administration's 'Most Favored Nation' drug pricing policy raises concerns for pharmaceutical companies regarding clinical development and NIH funding.…
Read More » -
Events
ReImagine Pharma Marketing East 2025 Delivers Timely Insights and Meaningful Connections in Princeton, NJ
The ReImagine Pharma Marketing East Conference recently convened top pharmaceutical marketing minds in Princeton, NJ, for a high-impact event lauded…
Read More » -
AI
Unlocking Personalized Patient Support: Five AI Insights
Early applications of artificial intelligence in patient support services are revealing valuable lessons about implementation and impact. These insights highlight…
Read More » -
Pharma News
US Considers Pharmaceutical Tariffs: Industry Braces for Potential Impact
The Trump administration is considering tariffs on pharmaceuticals to boost domestic production, citing national security concerns. This has put the…
Read More » -
AI
Pharma’s Digital Leap: Generative AI and the Future of Drug Innovation
Generative AI and digital workers are poised to revolutionize the pharmaceutical industry, streamlining drug discovery and ensuring rigorous regulatory compliance.…
Read More » -
Events
Pharma USA 2025: Where Industry Leaders Shaped the Future
Pharma USA 2025 served as a crucial platform for exploring the evolving pharmaceutical landscape, emphasizing patient-centric approaches and the integration…
Read More » -
Pharma News
Healthcare Research in Flux: Impact of Potential Funding Cuts
Proposed federal healthcare spending cuts threaten to slow biomedical research by impacting NIH and FDA operations, potentially hindering drug development…
Read More » -
Clinical Trials
Inborn Errors of Metabolism: Gene Therapy’s Potential and Challenges
While gene therapy offers hope for correcting the underlying genetic defects in inborn errors of metabolism (IEMs), progress is hampered…
Read More »